SC 13G: Sanara MedTech Inc.
Ticker: SMTI · Form: SC 13G · Filed: Oct 8, 2024 · CIK: 714256
| Field | Detail |
|---|---|
| Company | Sanara Medtech Inc. (SMTI) |
| Form Type | SC 13G |
| Filed Date | Oct 8, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Sanara MedTech Inc..
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G filing submitted by Sanara Medtech Inc. (ticker: SMTI) to the SEC on Oct 8, 2024.
What is the risk level of this SC 13G filing?
This filing has been assessed as low risk.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securiti).
How long is this filing?
Sanara Medtech Inc.'s SC 13G filing is 3 pages with approximately 1,040 words. Estimated reading time is 4 minutes.
Where can I view the full SC 13G filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 1,040 words · 4 min read · ~3 pages · Grade level 9.3 · Accepted 2024-10-08 17:36:55
Key Financial Figures
- $0.001 — INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securiti
Filing Documents
- z108245sc13g.htm (SC 13G) — 52KB
- 0001214659-24-017309.txt ( ) — 54KB
(a)
Item 1(a). Name of Issuer: Sanara Medtech, Inc
(b)
Item 1(b). Address of Issuer’s Principal Executive Offices: 1200 Summit Ave, Suite 414, Fort Worth, Texas 76102
(a)
Item 2(a). Name of Person Filing: Christopher M. Plahm
(b)
Item 2(b). Address of Principal Business Office or, if none, Residence: 1010 Jorie Blvd., Suite 144 Oakbrook, IL 60523
(c)
Item 2(c). Citizenship: USA
(d)
Item 2(d). Title of Class of Securities: Common Stock, $0.001 par value
(e)
Item 2(e). CUSIP Number: 79957L100 Page 4 of 7 Item 3. If this Statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) ¨ Broker or dealer registered under Section 15 of the Act; (b) ¨ Bank as defined in Section 3(a)(6) of the Act; (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act; (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940; (e) x An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) ¨ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) ¨ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; (j) ¨ A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); (k) ¨ Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned: 612,937 (b) Percent of Class: 7.2% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: (ii) shared power to vote or to direct the vote: 612,937 (iii) sole power to dispose or to direct the disposition of: (iv) shared power to dispose or to direct the disposition of: Page 5 of 7 Item 5. If this statement is being filed to report the fact that as of the date hereof the repo